RVMD Stock Rises on FDA Breakthrough Therapy Designation Amid High Price-to-Sales Valuation
· gurufocus.com
On September 14, 2026, Revolution Medicines Inc (NASDAQ: RVMD) announced that the FDA granted Breakthrough Therapy designation to its drug Rasonque for use alon
On September 14, 2026, Revolution Medicines Inc (NASDAQ: RVMD) announced that the FDA granted Breakthrough Therapy designation to its drug Rasonque for use alon...